We can detect tumors earlier than ever before. Can we predict whether they’re going to be dangerous? We’ve tended to focus on the cancer, but its host tissue—“soil,” rather than “seed”—could help us predict the danger it poses. Over the summer of 2011, the water in Lake Michigan turned crystal clear. Shafts of angled light lit … Continued
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an impressive $68 million, backing from Celgene and some big-name execs. The Montreal and Cambridge, Massachusetts, biotech saw founding investor Versant Ventures co-lead the series A round with MPM Capital. They were also joined by other syndicate investors … Continued
SIX NEW YORK CITY SCIENTISTS WIN PERSHING SQUARE SOHN PRIZE FOR YOUNG INVESTIGATORS IN CANCER RESEARCH The Pershing Square Sohn Research Alliance Continues Investment in the Next Generation of Medical Research Talent to Accelerate Breakthroughs in Cancer Research NEW YORK, May 8, 2017 – The Pershing Square Sohn Cancer Research Alliance today announced the six … Continued
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have received two grants from the Sohn Conference Foundation to advance their investigation into how cancer spreads in children. Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology and a professor of pediatrics, Dr. Haiying Zhang, an assistant professor of cell and … Continued
Some people struggle to find their paths in life. Not Chris Mason, PhD, Associate Professor and geneticist at Weill Cornell Medicine in New York City. He had already determined he wanted to be a geneticist by the time he reached eighth grade. “I was—and still am—a curious kid. I wanted to know how the world … Continued
Ali Brivanlou slides open a glass door at the Rockefeller University in New York to show off his latest experiments probing the mysteries of the human embryo. “As you can see, all my lab is glass — just to make sure there is nothing that happens in some dark rooms that gives people some weird … Continued
PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2017 Prize for Young Investigators in Cancer Research
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue explorative and high-risk/high-reward research at a stage when traditional funding is lacking.
The Pershing Square Sohn Cancer Research Alliance (“the Alliance”) today announced seven winners of the third annual Pershing Square Sohn Prize for Young Investigators in Cancer Research (“the Pershing Square Sohn Prize”). Each will receive $200,000 in funding per year for up to three years to enable them to continue to pursue explorative and high-risk/high-reward research.